Vaccination against herpes zoster and postherpetic neuralgia in France: a cost–effectiveness analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost–effectiveness analysis
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 13, Issue 3, Pages 393-406
Publisher
Informa UK Limited
Online
2013-03-29
DOI
10.1586/erp.13.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
- (2013) Thomas D. Szucs et al. PHARMACOECONOMICS
- Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- Vaccination contre la grippe saisonnière en France en 2010 et 2011 : diminution des taux de couverture et facteurs associés
- (2012) Philippe Tuppin et al. PRESSE MEDICALE
- The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
- (2011) Marc Brisson et al. Human vaccines & immunotherapeutics
- Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland
- (2011) Thomas D. Szucs et al. Human vaccines & immunotherapeutics
- Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: Review of international publications
- (2011) J. Bruxelle et al. MEDECINE ET MALADIES INFECTIEUSES
- Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice
- (2011) Didier Bouhassira et al. PAIN
- Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
- (2010) Alies van Lier et al. BMC HEALTH SERVICES RESEARCH
- The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
- (2010) Robert W Johnson et al. BMC Medicine
- Évaluation de l’incidence du zona, de la proportion des douleurs post-zostériennes, et des coûts associés dans la population française de 50 ans ou plus
- (2010) G. Mick et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Herpes zoster: Burden of disease in France
- (2010) S. Gonzalez Chiappe et al. VACCINE
- Herpes Zoster Pain, Postherpetic Neuralgia, and Quality of Life in the Elderly
- (2010) Gisèle Pickering et al. Pain Practice
- Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium
- (2010) L. Annemans et al. JOURNAL OF MEDICAL ECONOMICS
- Herpes Zoster (Shingles) and Postherpetic Neuralgia
- (2009) Priya Sampathkumar et al. MAYO CLINIC PROCEEDINGS
- Cost Effectiveness of Herpes Zoster Vaccine in Canada
- (2009) Mehdi Najafzadeh et al. PHARMACOECONOMICS
- Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
- (2009) A.J. van Hoek et al. VACCINE
- Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
- (2008) A. GAUTHIER et al. EPIDEMIOLOGY AND INFECTION
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
- (2008) Kenneth Schmader et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination against Herpes Zoster and Postherpetic Neuralgia
- (2008) Michael N. Oxman et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started